FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4522111000001104: Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21334101000001118 Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21334201000001113 Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Is pack of Pergolide 50micrograms tablet and pergolide 250micrograms tablet starter pack false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Has active ingredient Pergolide false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Has VMP Pergolide 50micrograms tablet and pergolide 250micrograms tablet starter pack false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Has VMP Pergolide 250microgram tablets and Pergolide 50microgram tablets false Inferred relationship Existential restriction modifier
Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Has VMP Pergolide 250microgram tablets and Pergolide 50microgram tablets true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Celance tablets 30 day starter pack (Eli Lilly & Co Ltd) 166 tablet 1 x (109 tablets + 57 tablets) Is a True Pergolide 250microgram tablets and Pergolide 50microgram tablets 166 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start